Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3293 (104th)

Safe Drinking Water Estrogenic Substances Screening Program Act

referredUnited States· United States Congress· EN

Introduced

23 April 1996

Last action

26 April 1996 · Referred

Status

Referred to the Subcommittee on Health and Environment.

Sponsors

Rep. Lowey, Nita M. [D-NY-17], Rep. Shays, Christopher [R-CT-4], Sen. Markey, Edward J. [D-MA], Sen. Sanders, Bernard [I-VT], Rep. Owens, Major R. [D-NY-11], Rep. Foglietta, Thomas M. [D-PA-1], Rep. Green, Gene [D-TX-29], Rep. Porter, John Edward [R-IL-10], Rep. Bonior, David E. [D-MI-10], Rep. Dellums, Ronald V. [D-CA-9], Rep. Waxman, Henry A. [D-CA-33], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Morella, Constance A. [R-MD-8]

Subjects

Healthcare, Environment

Source updated

3 June 2026

Healthcare · Environment

Summary

Safe Drinking Water Estrogenic Substances Screening Program Act - Amends the Safe Drinking Water Act to require the Administrator of the Environmental Protection Agency to develop and, under specified conditions, implement a screening program, using appropriate validated test systems, to determine whether certain substances (including all active and inert ingredients used in registered pesticides) may have an effect in humans that is similar to an effect produced by a naturally occurring estrogen, or such other endocrine effect as the Administrator may designate. Allows the Administrator to exempt a biologic or other substance if the Administrator determines that the substance does not have any effect in humans similar to an effect produced by a naturally occurring estrogen. Requires the Administrator to order a manufacturer of a substance for which such testing is required to conduct such testing and submit results within a certain time period. Provides for suspension of the sale or distribution of the substance if the manufacturer fails to submit required information. Requires the Administrator to: (1) take such action as is necessary to ensure the protection of public health in the case of any substance that is found to have a potential adverse effect on humans; and (2) report findings and recommendations to the Congress.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 23 April 1996

    Introduced

    Referred to the House Committee on Commerce.

    Source: IntroReferral

  2. 23 April 1996

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 23 April 1996

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 26 April 1996

    Referred

    Referred to the Subcommittee on Health and Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 23 April 1996

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 23 April 1996

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 23 April 1996

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.